Skip to main content
Download PDF

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

World Journal of Surgical Oncology volume 21, Article number: 54 (2023) Cite this article

The Original Article was published on 02 September 2021

Correction: World J Surg Onc 19, 264 (2021)

https://doi.org/10.1186/s12957-021-02361-9

Following publication of the original article [1], the author reported an error in the “Funding“ section.

“This Project was supported by the Istanbul University, Department of Scientific Research Projects (ID26409/TTU-2017-26409), and the Istanbul Breast Society. “

Should be:

This Project was supported by the Istanbul University, Department of Scientific Research Projects (ID26409/TTU-2017-26409), (ID27023/TOA-2017-27023) and the Istanbul Breast Society.

The original article has been updated.

Reference

  1. Oner G, Önder S, Karatay H, et al. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy. World J Surg Onc. 2021;19:264. https://doi.org/10.1186/s12957-021-02361-9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Gizem Oner, Mustafa Tükenmez, Mahmut Müslümanoğlu, Abdullah İğci, Ahmet Dincçağ, Vahit Özmen & Neslihan Cabioğlu

  2. Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium

    Gizem Oner

  3. Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium

    Gizem Oner

  4. Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Semen Önder, Hüseyin Karatay & Ekrem Yavuz

  5. Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey

    Naziye Ak & Adnan Aydiner

Authors
  1. Gizem Oner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Semen Önder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hüseyin Karatay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naziye Ak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mustafa Tükenmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahmut Müslümanoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abdullah İğci
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ahmet Dincçağ
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vahit Özmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Adnan Aydiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ekrem Yavuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Neslihan Cabioğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neslihan Cabioğlu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oner, G., Önder, S., Karatay, H. et al. Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy. World J Surg Onc 21, 54 (2023). https://doi.org/10.1186/s12957-023-02931-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12957-023-02931-z

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us